tetryzoline
Small moleculeapproved
Approved
Nov 30, 1979
Tetrahydrozoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray (Tyzin) for decongestion of nasal and nasopharyngeal mucosa. — NCATS
Clinical trial activity
4 trials · 5 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
2
Earliest trial started Jan 1, 2009 (NCT01380678)
Timeline
Indications
Approved for
Mechanism of action
Approval history
- approvedNov 30, 1979
Chemistry & pharmacology
Loading structure…
SMILES
c1ccc2c(c1)CCCC2C1=NCCN1- Mol. weight
- 200.28 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- ChEMBLCHEMBL1266 ↗
- WikipediaTetryzoline ↗
- NCATSS9U025Y077 ↗
- ChEMBLCHEMBL1200791 ↗
- ChEMBLCHEMBL1200413 ↗
Also known as
- 2-(1,2,3,4-tetrahydro-1-naphthyl)-2-imidazoline
- berberil n
- caltheon
- collyrium fresh
- diabenyl t
- dl-tetrahydrozoline
- eye-sine
- eye-zine
- murine plus
- murine sore eyes
- ocuzolin
- ophtalmin
- optazine fresh
- optigene
- rhinopront
- (rs)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1h-imidazole
- (rs)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1h-imidazole
- tetraclear
- tetrahydrozeline hcl
- tetrahydrozeline hydrochloride
- tetrahydrozeline nitrate
- tetrahydrozoline
- tetrahydrozoline
- tetrahydrozoline
- tetrahydrozoline
- tetrahydrozoline
- tetrahydrozoline
- tetrahydrozoline
- (+/-)-tetrahydrozoline
- tetrahydrozoline hcl
- tetrahydrozoline hcl
- tetrahydrozoline hcl
- tetrahydrozoline hydrochloride
- tetrahydrozoline hydrochloride
- tetrahydrozoline hydrochloride
- tetrahydrozoline hydrochloride
- tetrahydrozoline hydrochloride
- tetrahydrozoline, (-)-isomer
- tetrahydrozoline, (+-)-isomer
- tetrahydrozoline monohydrochloride
- tetrahydrozoline nitrate
- tetrahydrozoline nitrate
- tetrahydrozoline nitrate
- tetrahydrozoline nitrate
- tetrahydrozoline nitrate
- tetra-ide
- tetrilin
- tetrizolina
- tetrizolina
- tetryzolin
- tetryzolin
- tetryzolin
- tetryzoline
- tetryzoline
- tetryzoline
- tetryzoline
- tetryzoline
- tetryzoline
- tetryzoline
- tétryzoline
- tétryzoline
- tetryzoline hcl
- tetryzoline hcl
- tetryzolinum
- tetryzolinum
- tyzine
- tyzine
- tyzine
- tyzine
- vasopos
- visine
- visine
- visine
- visine
- visine l.r.
- visine l.r.
- vispring
- yxin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05028907 | Phase 4 | Nov 15, 2020 | Sohag University |
| NCT03198000 | Phase 3 | Jun 28, 2017 | Andover Eye Associates, Johnson and Johnson |
| NCT01105624 | Phase 4 | Mar 1, 2010 | Merck |
| NCT01380678 | Phase 3 | Jan 1, 2009 | KhonKaen University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Andover Eye Associates | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2017 |
| KhonKaen University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Merck | For profit | 1 | 1 | 1 | 2010 |
| Sohag University | Academic/Hospital | 1 | 1 | 1 | 2020 |
5 organizations
Page 1 / 1